Statistics
Publications
2
Citations
578
H-Index
2
Active since
2022
Affiliations
Boehringer Ingelheim (Austria)(Current)
Joachim Bröker is an author at Boehringer Ingelheim (Austria) specializing in enzyme inhibition, ligand binding, and kras inhibitors.
Publications per year
2022–2023
2
2
Pan-KRAS inhibitor disables oncogenic signalling and tumour growth
Dong-Sung Kim, Lorenz Herdeis, Dorothea Rudolph et al. · Nature · 2023 · 497 citations · Full text
Medicine, Oncology, Pharmacology +17
Joachim Bröker, Alex G. Waterson, Chris A. Smethurst et al. · Journal of Medicinal Chemistry · 2022 · 81 citations · Full text
1–2 of 2